NGOs have long denounced lower-income countries’ inequitable access to COVID-19 vaccines and treatments. But the zero draft of the pandemic accord released Wednesday is giving them some hope that this may change in the next pandemic.
Several of them were pleased to see support for intellectual property waivers, as well as transparency and access conditions over publicly funded medical products.
“The several conditions on R&D and procurement contracts echo what many have been calling for, and really they hit on the core issues of concern,” James Love, director of Knowledge Ecology International, told Devex.
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Jenny Lei Ravelo@JennyLeiRavelo
Jenny Lei Ravelo is a Devex Senior Reporter based in Manila. She covers global health, with a particular focus on the World Health Organization, and other development and humanitarian aid trends in Asia Pacific. Prior to Devex, she wrote for ABS-CBN, one of the largest broadcasting networks in the Philippines, and was a copy editor for various international scientific journals. She received her journalism degree from the University of Santo Tomas.
